Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits
mediaposted on 2021-06-07, 09:21 authored by Adis journals on behalf of, Mark G Lebwohl, Emil A Tanghetti, Linda Stein Gold, James Q Del Rosso, Nelly K Gilyadov, Abby Jacobson
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.